💡 Board approved strong standalone profit growth for 9M FY26, driven by a significant one-time gain from the Ebix UK settlement.
What Happened
The Board of Directors of Vikas Lifecare Limited approved the unaudited financial results for the quarter and nine months ended December 31, 2025. The standalone results show a significant profit before tax of ₹10,439.41 lakhs for the nine-month period, a major improvement from a loss of ₹355.24 lakhs in the previous full year. This performance is largely attributed to a one-time gain from the settlement of an arbitration related to the acquisition of a 51% stake in Ebix International Holdings Limited (Ebix UK).
Key Details
- Company: Vikas Lifecare Limited
- Event Type: Earnings
- Filing Date: 22-Apr-2026 00:14:30
- NSE Filing: View Document
Why It Matters
The filing indicates a substantial positive swing in the company's profitability for the first nine months of FY26. The key driver is a non-recurring gain from the settlement of a prior investment in Ebix UK, which has been accounted for in the results. While this provides a significant boost to the current period's earnings, investors should note the one-off nature of this gain. The core operational performance and the company's strategy for integrating or realizing value from the Ebix UK stake will be important factors for future performance.
Disclaimer: This is publicly available information sourced from NSE. Not investment advice.
Get signals like this instantly
Free Telegram alerts within 2 minutes of NSE filing
Join SuperStock Free